ergotamine (Ergostat)

From Aaushi
Jump to navigation Jump to search

Introduction

Tradename: Ergostat.

Indications

Contraindications

Dosage

  • 2 mg SL, may repeat every 30 min X 2
  • Max 5 tabs/week

Tabs: 2 mg.

Pharmacokinetics

elimination via liver

Adverse effects

Drug interactions

Mechanism of action

More general terms

Component of

References

  1. The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
  2. Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998 - not on National VA formulary
  3. Prescriber's Letter 14(4): 2007 FDA takes action to halt marketing of upapproved ergotamine Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=230406&pb=PRL (subscription needed) http://www.prescribersletter.com
  4. 4.0 4.1 Deprecated Reference

Database